Penumbra 

$329.29
47
+$0.92+0.28% Today

Statistics

Day High
330.44
Day Low
328.1
52W High
362.41
52W Low
221.26
Volume
404,094
Avg. Volume
1,042,350
Mkt Cap
12.92B
P/E Ratio
60.31
Dividend Yield
-
Dividend
-

Upcoming

Earnings

5MayExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Next
0.67
0.84
1.01
1.18
Expected EPS
1.063928
Actual EPS
N/A

Financials

12.66%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
2.81BRevenue
355.37MNet Income

Analyst Ratings

$370.08Average Price Target
The highest estimate is 374.00.
From 14 ratings within the last 6 months. This is not an investment recommendation.
Buy
21%
Hold
79%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow PEN. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Boston Scientific
BSX
Mkt Cap149.24B
Boston Scientific offers a wide range of medical devices that compete with Penumbra's neurovascular and peripheral vascular products.
Medtronic
MDT
Mkt Cap116.33B
Medtronic provides medical devices for various conditions, including those that overlap with Penumbra's market, such as neurovascular devices.
Smith & Nephew
SNN
Mkt Cap15.61B
Smith & Nephew competes in the medical technology market, offering products that can be used in similar procedures as Penumbra's.
Stryker
SYK
Mkt Cap136.19B
Stryker operates in the medical technology field, offering neurotechnology and spine products that compete with Penumbra's offerings.
Zimmer Biomet
ZBH
Mkt Cap19.92B
Zimmer Biomet competes in the musculoskeletal healthcare market, which can overlap with Penumbra's interventional therapies.
Edwards Lifesciences
EW
Mkt Cap48.41B
Edwards Lifesciences specializes in heart valves and hemodynamic monitoring, competing in the broader cardiovascular market with Penumbra.
Intuitive Surgical
ISRG
Mkt Cap189.4B
Intuitive Surgical, known for its robotic surgical systems, competes in the high-tech end of medical devices, indirectly competing with Penumbra's innovative solutions.
Johnson & Johnson
JNJ
Mkt Cap455.04B
Johnson & Johnson, through its medical devices segment, offers a broad range of products that compete across several of Penumbra's markets.
Integra Lifesciences
IART
Mkt Cap935.48M
Integra LifeSciences offers products in neurosurgery, reconstructive and general surgery, directly competing with some of Penumbra's surgical solutions.

About

Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral thrombectomy products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX, BENCHMARK, BMX, DDC, MIDWAY, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization device, aspiration tubing, and aspiration pump under the Penumbra RED, SENDit, JET, ACE, BMX, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that includes the Penumbra Coil 400, a detachable coil that provides an alternative for the treatment of aneurysms and other complex lesions, as well as detachable coils to treat patients with a wide range of neurovascular lesions under the Penumbra SMART COIL and Penumbra SwiftPAC Coil brands; and POD400 and PAC400 brands. In addition, the company provides peripheral embolization products, such as Ruby Coil System consisting of detachable coils for peripheral applications; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers neurosurgical tools comprising Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. The company sells its products through direct sales organizations and distributors. Penumbra, Inc. was incorporated in 2004 and is headquartered in Alameda, California.
Show more...
CEO
Mr. Adam Elsesser J.D.
Employees
4500
Country
US
ISIN
US70975L1070

Listings

0 Comments

Share your thoughts

FAQ

What is Penumbra stock price today?
The current price of PEN is $329.29 USD — it has increased by +0.28% in the past 24 hours. Watch Penumbra stock price performance more closely on the chart.
What is Penumbra stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Penumbra stocks are traded under the ticker PEN.
Is Penumbra stock price growing?
PEN stock has fallen by -2.1% compared to the previous week, the month change is a -4.4% fall, over the last year Penumbra has showed a +21.43% increase.
What is Penumbra market cap?
Today Penumbra has the market capitalization of 12.92B
When is the next Penumbra earnings date?
Penumbra is going to release the next earnings report on May 05, 2026.
What were Penumbra earnings last quarter?
PEN earnings for the last quarter are 1.18 USD per share, whereas the estimation was 1.11 USD resulting in a +6.06% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Penumbra revenue for the last year?
Penumbra revenue for the last year amounts to 2.81B USD.
What is Penumbra net income for the last year?
PEN net income for the last year is 355.37M USD.
How many employees does Penumbra have?
As of April 01, 2026, the company has 4,500 employees.
In which sector is Penumbra located?
Penumbra operates in the Health Care sector.
When did Penumbra complete a stock split?
Penumbra has not had any recent stock splits.
Where is Penumbra headquartered?
Penumbra is headquartered in Alameda, US.